TNXP Tonix Pharmaceuticals Holding Corp — Stock Price and ... Securities products and services offered to self-directed investors through ST Invest, LLC. Member FINRA / SIPC.ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. Please read important legal disclosures. Titan Pharmaceuticals, Inc. (TTNP) Stock Forum ... Find the latest Titan Pharmaceuticals, Inc. (TTNP) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. TTNP Stock Price | Titan Pharmaceuticals Inc. Stock Quote ...
TTNP - Titan Pharmaceuticals Inc Stock quote - CNNMoney.com
Stock Price Forecast for TTNP: Titan Pharmaceuticals holds several negative Important: Please note that 83% of user opinions on StockTwits are positive to Analyzing Titan Pharmaceuticals (NASDAQ:TTNP) stock? View TTNP's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC Tap into the pulse of the markets and cryptocurrency trading with Stocktwits. Use StockTwits to catch up quickly on the stocks you care about and new market All the best to you and yours. $BZUN to the Moon I have been known to shout on StockTwits. If you're looking for stocks that are quantitatively similar to Amyris Inc, a group of peers worth examining would be ACUR, SENS, RWLK, VSTM, and TTNP. Charles Schwab – trading app · Investing.com – stock news app · StockTwits TTNP, Titan Pharmaceuticals, Inc. - Common Stock, 8721576, Healthcare. NE 11 Oct 2017 Titan Pharmaceuticals (NSDQ:TTNP) has treated the first patient in a Phase I/II trial of its ropinirole implant designed to treat the signs and
Analyzing Titan Pharmaceuticals (NASDAQ:TTNP) stock? View TTNP's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC
Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. Events :: Titan Pharmaceuticals, Inc. (TTNP) There are no upcoming events scheduled at this time. Sign up here to receive notices about upcoming events and press releases. TTNP | Stock Snapshot - Fidelity Apr 03, 2020 · Stock quote and company snapshot for TITAN PHARMACEUTICALS INC (TTNP), including profile, stock chart, recent news and events, analyst opinions, and research reports. Skip to Main Content. Site navigation StockTwits Read live tweets from the financial and investing community about the stock you're interested in. Titan Pharmaceuticals, Inc. - TTNP - Stock Price Today - Zacks
Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. It develops products based on ProNeura, a proprietary long-term drug delivery platform that focuses primarily on the treatment for chronic diseases.
Zacks Small Cap Research - TTNP: Shipments Spike in 2H:18 By John Vandermosten, CFA NASDAQ:TTNP We have now had more than two full quarters of in-house management of Probuphine commercialization by Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) and indications are that shipment trends are strong. Since the company had their licenses returned in late May 2018 Titan has implemented a new strategy to grow sales for the innovative Titan Pharmaceuticals And Molteni Receive European ...
Stocktwits on the App Store
TTNP Earnings Date, Forecast and Report (Titan ... Share on Stocktwits. (NASDAQ:TTNP) Earnings Information. Titan Pharmaceuticals last posted its earnings data on March 30th, 2020. The specialty pharmaceutical company reported ($0.08) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.08). The company had revenue of $1.22 million for the quarter, compared to TTNP Stock Price & Charts | Titan Pharmaceuticals Jan 25, 2019 · Description: Titan Pharmaceuticals Inc is a specialty pharmaceutical company. It is engaged in the development and commercialization of pharmaceutical products. The company product pipeline consists of Probuphine for Opioid addiction, Ropinirole for Parkinson's disease, Triiodothyronine (T3) for hypothyroidism. TTNP Tweets Stocktwits Titan Pharmaceuticals, Inc. Common Stock (TTNP) Stock ... Titan Pharmaceuticals, Inc. Common Stock (TTNP) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.
Titan Pharmaceuticals, Inc. - TTNP - Stock Price Today - Zacks View Titan Pharmaceuticals, Inc. TTNP investment & stock information. Get the latest Titan Pharmaceuticals, Inc. TTNP detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Titan Pharmaceuticals, Inc. (TTNP) SEC Filings | Seeking Alpha Latest SEC filings for Titan Pharmaceuticals, Inc. (TTNP). Titan Pharmaceuticals, Inc. - TheStreet Titan Pharmaceuticals (TTNP) Stock Soars on FDA Committee Treatment Approval. By Amanda Albright. Jan 13, 2016 10:15 AM EST. OPINION. 4 Biotech Stocks Under $10 to Trade for Big Breakouts.